Search Results - "Dorman, Susan"
-
1
Latent Tuberculosis Infection
Published in The New England journal of medicine (09-12-2021)“…Persons with risk factors for Mycobacterium tuberculosis exposure or for progression to tuberculosis disease should be tested for M. tuberculosis infection,…”
Get full text
Journal Article -
2
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Published in Clinical infectious diseases (01-10-2016)“…The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America jointly sponsored the development of this…”
Get full text
Journal Article -
3
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Published in Clinical infectious diseases (01-10-2016)“…The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America jointly sponsored the development of this…”
Get full text
Journal Article -
4
New Diagnostic Tests for Tuberculosis: Bench, Bedside, and Beyond
Published in Clinical infectious diseases (15-05-2010)“…Current tools and strategies for diagnosis of tuberculosis (TB) are inadequate, particularly in settings with a high prevalence of human immunodeficiency virus…”
Get full text
Journal Article -
5
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
Published in The Lancet infectious diseases (01-01-2018)“…The Xpert MTB/RIF assay is an automated molecular test that has improved the detection of tuberculosis and rifampicin resistance, but its sensitivity is…”
Get full text
Journal Article -
6
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Published in The New England journal of medicine (06-05-2021)“…In this phase 3 trial for the treatment of tuberculosis, a 4-month rifapentine-based regimen containing moxifloxacin was noninferior to a standard 6-month…”
Get full text
Journal Article -
7
Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach
Published in PLoS medicine (25-07-2024)“…In the Perspective, William Burman and colleagues advocate improving the safety and acceptability of treatment, rather than treatment-shortening, of…”
Get full text
Journal Article -
8
Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa
Published in BMC infectious diseases (29-07-2013)“…The World Health Organization has endorsed the use of molecular methods for the detection of TB and drug-resistant TB as a rapid alternative to culture-based…”
Get full text
Journal Article -
9
Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics
Published in PloS one (07-04-2021)“…Lipoarabinomannan (LAM), an amphiphilic lipoglycan of the Mycobacterium tuberculosis cell wall, is a diagnostic target for tuberculosis. Previous work from our…”
Get full text
Journal Article -
10
Diagnosis of HIV-associated tuberculosis
Published in Current opinion in HIV & AIDS (01-11-2018)“…PURPOSE OF REVIEWThe current review highlights recent advances in tuberculosis (TB) diagnostics that are relevant for clinicians engaged in the care of…”
Get full text
Journal Article -
11
Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection
Published in Respiratory medicine (01-01-2023)“…There is an increasing prevalence of nontuberculous mycobacteria pulmonary disease (NTM-PD) in the US. Treatment of NTM-PD typically requires multiple…”
Get full text
Journal Article -
12
Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States
Published in American journal of respiratory and critical care medicine (01-01-2014)“…IFN-γ release assays (IGRAs) are alternatives to tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection. Limited data suggest IGRAs may…”
Get full text
Journal Article -
13
Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection
Published in American journal of respiratory and critical care medicine (15-09-2020)“…Rifapentine has been investigated at various doses, frequencies, and dosing algorithms but clarity on the optimal dosing approach is lacking. In this…”
Get full text
Journal Article -
14
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results
Published in American journal of respiratory and critical care medicine (01-04-2023)“…Pretomanid is a new nitroimidazole with proven treatment-shortening efficacy in drug-resistant tuberculosis. Pretomanid-rifamycin-pyrazinamide combinations are…”
Get full text
Journal Article -
15
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
Published in Nature genetics (01-03-2017)“…Ashlee Earl and colleagues analyze whole-genome sequences from 5,310 Mycobacterium tuberculosis isolates from five continents. They find that resistance to…”
Get full text
Journal Article -
16
Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis
Published in PloS one (18-12-2013)“…High costs are a limitation to scaling up the Xpert MTB/RIF assay (Xpert) for the diagnosis of tuberculosis in resource-constrained settings. A triaging…”
Get full text
Journal Article -
17
Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid
Published in Clinical infectious diseases (22-08-2020)“…Abstract Background Tuberculosis (TB) control is hindered by absence of rapid tests to identify Mycobacterium tuberculosis (MTB) and detect isoniazid (INH) and…”
Get full text
Journal Article -
18
Four-Month Rifapentine Regimens for Tuberculosis
Published in The New England journal of medicine (17-03-2022)“…To the Editor: Dorman et al. (May 6 issue) 1 found that a 4-month rifapentine-based, moxifloxacin-containing regimen was noninferior to the standard 6-month…”
Get full text
Journal Article -
19
Four-Month Rifapentine Regimens for Tuberculosis. Reply
Published in The New England journal of medicine (17-03-2022)Get full text
Journal Article -
20
From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis
Published in Nature medicine (01-03-2007)“…Extensively drug-resistant tuberculosis (XDR-TB) occurs where health systems have been historically weak; it lays bare the reality of TB as a serious public…”
Get full text
Journal Article